management of adverse events for alk-targeted tkis
Published 5 years ago • 31 plays • Length 4:04Download video MP4
Download video MP3
Similar videos
-
2:34
afatinib: dose modifications and adverse events
-
5:57
adverse events of second-generation tkis used in treating cml
-
3:12
hcc whiteboard #3: the management of adverse events of tyrosine kinase inhibitors
-
3:31
the evolution of alk/ros1-targeted tkis
-
6:21
the management of cardiovascular events
-
5:56
tki therapy: impact of age and adverse events
-
8:02
updates informing the management of alk-rearranged mnsclc
-
7:00
case 1: differences in ar-targeted therapy adverse events in nmcrpc
-
0:44
alk-tkis: targeted therapies for alk-positive nsclc
-
4:44
managing crt-related adverse events in nsclc
-
30:32
2023 best of lung: targeted therapies in lung cancer
-
1:05
what targeted therapies are used for people with the alk mutation?
-
2:19
dr. sweis on the management of tki-associated adverse events in kidney cancer
-
41:23
multimodal management of early-stage nsclc: egfr-targeted therapy in perioperative settings
-
6:17
introduction to alk inhibitors
-
2:48
targeted therapy resistance mechanisms in alk nsclc
-
20:24
targeted treatment with egfr tkis: front line options
-
2:16
adverse effects and braf inhibitors in mnsclc
-
6:36
sequencing strategies for alk-targeted therapy